Regulatory Approval

LONDON--()--

ECO Animal Health Group plc
(AIM: EAH)

ECO RECEIVES MALAYSIAN MARKETING AUTHORISATION FOR AIVLOSIN® FOR CHICKENS LAYING EGGS FOR HUMAN CONSUMPTION

ECO Animal Health Group plc is pleased to announce that its subsidiary ECO Animal Health Limited (ECO) has received a marketing authorisation from the National Pharmaceutical Regulatory Agency of Malaysia for the use of Aivlosin® 625 mg/g water soluble granules in chickens laying eggs for human consumption.

This approval, the second in Southeast Asia, follows the European approval received in June 2016. ECO will start selling Aivlosin® in Malaysia for the medication of drinking water for the treatment of infections caused by Mycoplasma in poultry laying eggs for human consumption, with a zero day drug withdrawal period for eggs.

ECO has begun the process of submitting the Aivlosin® regulatory files for the treatment of layers in numerous other key egg producing markets.

Aivlosin®, ECO’s patented antimicrobial, is used under veterinary prescription for the treatment of a variety of economically important respiratory and enteric (gut) diseases in poultry and pigs.

Peter Lawrence, Chairman of ECO, commented “This approval is another important step in the development of Aivlosin® for commercial layers. Malaysia is ranked as a global top twenty egg producing country and home to four of the ten largest egg producers in Asia. This latest approval demonstrates ECO’s continued progress to becoming a major force in the international market for veterinary pharmaceutical products.”

This announcement contains inside information.

Contacts:

ECO Animal Health Group plc

Peter Lawrence   020 8336 6190
Marc Loomes 020 8447 6906
Spiro Financial
Anthony Spiro 020 8336 6196
Peel Hunt LLP (Nominated Adviser)
Dan Webster, Adrian Trimmings, George Sellar 020 7418 8900
N+1 Singer (Joint Broker) 020 7496 3000
Mark Taylor, Brough Ransom

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders

Category Code: REA
Sequence Number: 584434
Time of Receipt (offset from UTC): 20170602T125051+0100

Contacts

Eco Animal Health Group Plc

Contacts

Eco Animal Health Group Plc